None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Infants aged from 06 months to 09 months of either Gender. 2. Parentsâ?? willingness to let their children participate.
Exclusion criteria
Exclusion criteria: 1. Subjects suffering from major systemic illness necessitating long term treatment. 2. Co-morbidity like TB, UTI and bleeding disorders etc. 3. H/o hypersensitivity to any of the trial drug or their ingredients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To lower down the incidence of respiratory infection in infants with the use of trial drug.Timepoint: baseline and every 15th day up to completion of trial i.e. end of 4 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To promote the normal growth and development of infant with lowering the incidence of infection.Timepoint: Total trial period : 03 Months Follow-Up Period : 01 Month | — |
Countries
India
Contacts
National Institute of Ayurveda